Koers Aradigm Corporation Nasdaq
Aandelen
US0385054004
Biotechnologie & Medisch Onderzoek
Omzet 2016 | 195K 180K | Omzet 2017 | 14,46 mln. 13,37 mln. | Marktkapitalisatie | 97,3 mln. 89,96 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | -32 mln. -29,58 mln. | Nettowinst (verlies) 2017 | -10 mln. -9,25 mln. | EV/omzet 2016 | 73,3 x |
Nettoliquiditeiten 2016 | 9,37 mln. 8,66 mln. | Nettoschuld 2017 | 7,91 mln. 7,32 mln. | EV/omzet 2017 | 7,27 x |
K/w-verhouding 2016 |
-0,72
x | K/w-verhouding 2017 |
-9,3
x | Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 |
-
| Vrij verhandelbaar | 60,28% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,03% | 48,16 mld. | |
-0,10% | 41,73 mld. | |
+43,45% | 41,03 mld. | |
-5,26% | 28,77 mld. | |
+11,48% | 25,59 mld. | |
-22,74% | 18,96 mld. | |
+9,06% | 12,92 mld. | |
+30,01% | 12,03 mld. | |
-1,51% | 11,77 mld. |